INBX today
$87.45-$3.14 (-3.47%)close Nov 12, 2026Trend
DailyUptrend (starting)
4 hourStrong Bullish
1 hourStrong Bullish
15 minBullish
5 minConsolidating
Daily trend turns down below $57.30
Key levels
Resistance$107.90
Resistance$100.20
Support$83.61
Support$75.91
Latest news & SEC filings
SEC FilingInhibrx Biosciences, Inc. filed an insider trading report (Form 4)
All INBX news →About Inhibrx Biosciences
Inhibrx Biosciences is a clinical-stage biopharmaceutical company that creates biologic therapeutic candidates using its modular protein engineering platforms. Its main programs are ozekibart, a DR5 agonist in development for bone and soft tissue cancers and colorectal tumors, and INBRX-106, an OX40 agonist being tested in solid tumors. The company operates in the United States and focuses on oncology indications with limited treatment options.
Based on the company's 10-K filed Mar 19, 2026.
Nasdaq · Healthcare
Inhibrx Biosciences, Inc. (INBX)
What Is the Price Target for INBX?
SEPT Low Target
$167.88
SEPT Mid Target
$197.50
SEPT High Target
$227.12
Analyst Consensus
$197.50
Is INBX a Buy or Sell Right Now?
Thesis
- •Revenue growing 550.0% YoY with ACCELERATING trend — accelerating momentum.
- •SEC filings signal active product innovation — 1 new product/expansion keywords detected in 10-K. R&D investment stable.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for INBX.
Start Free Trial →Is INBX Overvalued or Undervalued?
Valuation Verdict
FAIR
Methods Used
P/B, Analyst Consensus
Fair Value
$148.81
15
Moat Score
NONE
2/9
Piotroski Score
1.1
Altman Z-Score
What Is Smart Money Doing with INBX?
Insider Signal
NEUTRAL
15 buys / 5 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Lappe Mark | director officer | Buy | 2,470 | $208K | Oct 14, 2026 |
| Lappe Mark | director officer | Buy | 100 | $9K | Oct 14, 2026 |
| Lappe Mark | director officer | Buy | 2,449 | $206K | Oct 14, 2026 |
| Lappe Mark | director officer | Buy | 2,451 | $208K | Oct 14, 2026 |
| Lappe Mark | director officer | Buy | 1,500 | $148K | Sep 28, 2026 |
| Lappe Mark | director officer | Buy | 3,000 | $305K | Sep 28, 2026 |
| Lappe Mark | director officer | Buy | 3,324 | $329K | Sep 25, 2026 |
| Lappe Mark | director officer | Buy | 2,176 | $217K | Sep 25, 2026 |
| Kayyem Jon Faiz | director | Buy | 5,000 | $500K | Sep 23, 2026 |
| Kayyem Jon Faiz | director | Buy | 5,000 | $500K | Sep 16, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →INBX Growth Story
Revenue YoY
550.0%
3yr Revenue CAGR
N/A%
EPS Growth YoY
-108.03%
FCF Growth YoY
34.1%
Revenue Trend
ACCELERATING
Dark Pool Trades for INBX
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for INBX, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 15:12:12 | $90.03 | 1,737 | $$156K | MIDPOINT |
| 15:11:06 | $90.03 | 1,100 | $$99K | MIDPOINT |
| 14:40:37 | $93.48 | 1,000 | $$93K | BUY |
| 17:41:04 | $90.61 | 1,000 | $$91K | SELL |
| 15:33:25 | $90.90 | 1,000 | $$91K | SELL |
5 dark pool trades shown · $$530K preview volume
Real-time institutional flow, block trades, and net positioning
What Traders Are Saying About INBX
4 postsSEPT Investing hosts an active community of 3,500+ traders sharing real-time analysis, trade setups, and market discussion for INBX. Join verified traders discussing price action, dark pool alerts, options flow, and AI-powered market intelligence.
Smart Money Moves $QFIN — Yan Andrew Y | Sale $3K $INBX — Lappe Mark | Sale $148K $INBX — Lappe Mark | Sale $305K $LILA — MALONE JOHN C | Sale $162K $VTIX — MOYER BRETT | Sale $10K
Smart Money Moves $INBX — Kayyem Jon Faiz | Sale $500K $LITE — Wupen Yuen | Sale $473K $NMAX — CONYERS INVESTMENTS LLC | Sale $4K $KBDC — ROBO JAMES L | Sale $1.2M $ONEN — Saade Javier | Sale
Smart Money Moves $LCLN — Heidloff Theodore J. | Sale $INBX — MANHARD KIMBERLY | Sale $53K $SMSI — Huffmyer Timothy C. | Sale $0K $GWRE — Peterson David Franklin | Sale $GLOO — THRIVENT FINANCIAL FOR...
Join 3,500+ traders discussing INBX in real-time
Trade ideas, setups, dark pool alerts, and AI-powered analysis
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Inhibrx Biosciences, Inc. (INBX) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →INBX — frequently asked questions
What is INBX stock price today?
Inhibrx Biosciences, Inc. (INBX) is at $87.45, down 3.47% (-$3.14) at the Nov 12, 2026 close.
Why is INBX stock moving today?
Latest INBX news — Oct 14, 2026: Inhibrx Biosciences, Inc. filed an insider trading report (Form 4)
What is the INBX price target?
The average analyst price target for INBX is $197.50, ranging from $150 to $245, based on 2 analysts. Latest: HC Wainwright & Co. initiates on Aug 24, 2026.
What do analysts rate INBX?
Analyst ratings for INBX: 0 Buy, 2 Hold, 0 Sell — consensus Hold.
Did INBX beat earnings?
INBX last reported on Aug 13, 2026: EPS -$2.34 vs -$2.28 expected — a miss of 2.6%.
Does INBX pay a dividend?
INBX does not currently pay a dividend.
What are INBX support and resistance levels?
Support: $83.61, $75.91, $66.80. Resistance: $100.20, $107.90, $117.14.
What are insiders doing with INBX?
Insider activity: NEUTRAL, 15 buys and 5 sells in the last 90 days.
What is the latest news on INBX?
Oct 14, 2026: Inhibrx Biosciences, Inc. filed an insider trading report (Form 4)